Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 208

    1.

    Management of hypertension in patients with type 2 diabetes mellitus: guidelines based on current evidence.

    Kaplan NM.

    Ann Intern Med. 2001 Dec 18;135(12):1079-83. Review.PMID: 11747387 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.

    Marshall SM.

    Diabet Med. 1999 May;16(5):358-72. Review.PMID: 10342335 [PubMed - indexed for MEDLINE]Related articles

    3.

    Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

    Taddei S, Ghiadoni L, Salvetti A.

    Drugs. 2003;63(14):1435-44. Review.PMID: 12834362 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.

    Vijan S, Hayward RA.

    Ann Intern Med. 2003 Apr 1;138(7):593-602. Review.PMID: 12667032 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

    Komers R, Anderson S.

    Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. Review.PMID: 10757223 [PubMed - indexed for MEDLINE]Related articles

    6.

    Arterial hypertension in diabetes mellitus: from theory to clinical practice.

    Sampanis C, Zamboulis C.

    Hippokratia. 2008 Apr;12(2):74-80.PMID: 18923653 [PubMed - in process]Related articlesFree article

    7.

    Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?

    Zanchetti A, Ruilope LM.

    J Hypertens. 2002 Nov;20(11):2099-110. Review.PMID: 12409940 [PubMed - indexed for MEDLINE]Related articles

    8.

    Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.

    Ferdinand KC.

    J Cardiometab Syndr. 2006 Spring;1(2):133-40. Review.PMID: 17679832 [PubMed - indexed for MEDLINE]Related articles

    9.

    Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J).

    Kawamori R, Daida H, Tanaka Y, Miyauchi K, Kitagawa A, Hayashi D, Kishimoto J, Ikeda S, Imai Y, Yamazaki T.

    BMC Cardiovasc Disord. 2006 Oct 9;6:39.PMID: 17029631 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C; Canadian Hypertension Education Program.

    Can J Cardiol. 2004 Jan;20(1):41-54.PMID: 14968142 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Lessons from trials in hypertensive type 2 diabetic patients.

    Ruilope LM.

    Curr Hypertens Rep. 2003 Aug;5(4):322-8. Review.PMID: 12844467 [PubMed - indexed for MEDLINE]Related articles

    12.

    Update on the management of hypertension: recent clinical trials and the JNC 7.

    Moser M.

    J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):4-13. Review.PMID: 15470293 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hypertension in people with Type 2 diabetes: knowledge-based diabetes-specific guidelines.

    Working Party of the International Diabetes Federation (European Region).

    Diabet Med. 2003 Dec;20(12):972-87. Review.PMID: 14632698 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

    Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

    Lancet. 2007 Sep 8;370(9590):829-40.PMID: 17765963 [PubMed - indexed for MEDLINE]Related articles

    15.

    Update on calcium antagonists and the kidney.

    Tobe S.

    Curr Opin Nephrol Hypertens. 2003 May;12(3):309-15. Review.PMID: 12698071 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Reduction of cardiovascular morbidity and mortality by combined antihypertensive drug therapy in patients with type 2 diabetes mellitus]

    Abrahamian H, Prager R.

    Wien Med Wochenschr. 2002;152(9-10):210-4. German. PMID: 12094390 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

    Thomas GN, Chan P, Tomlinson B.

    Drugs Aging. 2006;23(2):131-55. Review.PMID: 16536636 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Treatment of hypertension in type 2 diabetes mellitus--2002 update]

    Teuscher AU, Diem P.

    Ther Umsch. 2002 Aug;59(8):422-8. Review. German. PMID: 12235735 [PubMed - indexed for MEDLINE]Related articles

    19.

    What have we learned from the current trials?

    Abbott KC, Bakris GL.

    Med Clin North Am. 2004 Jan;88(1):189-207. Review.PMID: 14871059 [PubMed - indexed for MEDLINE]Related articles

    20.

    Renal protection in hypertensive patients: selection of antihypertensive therapy.

    Wenzel RR.

    Drugs. 2005;65 Suppl 2:29-39. Review.PMID: 16398060 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data